Lincoln National Corp’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,165
| Closed | -$24.9K | – | 1228 |
|
2023
Q4 | $24.9K | Sell |
3,165
-12,850
| -80% | -$101K | ﹤0.01% | 1094 |
|
2023
Q3 | $70.8K | Hold |
16,015
| – | – | ﹤0.01% | 1004 |
|
2023
Q2 | $557K | Buy |
16,015
+6,300
| +65% | +$219K | 0.01% | 562 |
|
2023
Q1 | $212K | Hold |
9,715
| – | – | ﹤0.01% | 910 |
|
2022
Q4 | $210K | Buy |
9,715
+2,050
| +27% | +$44.3K | ﹤0.01% | 857 |
|
2022
Q3 | $187K | Hold |
7,665
| – | – | ﹤0.01% | 820 |
|
2022
Q2 | $156K | Buy |
7,665
+2,500
| +48% | +$50.9K | ﹤0.01% | 819 |
|
2022
Q1 | $184K | Hold |
5,165
| – | – | ﹤0.01% | 872 |
|
2021
Q4 | $140K | Sell |
5,165
-7,500
| -59% | -$203K | ﹤0.01% | 862 |
|
2021
Q3 | $550K | Hold |
12,665
| – | – | 0.01% | 474 |
|
2021
Q2 | $631K | Buy |
+12,665
| New | +$631K | 0.01% | 427 |
|